We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Committees cite inappropriate collaboration between FDA and drugmaker
High production costs together with increasingly vegetarian appetites may prevent this industry taking off
FDA clears jabs despite lack of human trials in effort to curb winter wave of Covid infections
Shares in French pharma group tumble nearly 6% after blow to pipeline of new treatments
Supplies were intended to help with months-long shortage in America
Change would incorporate genetic material from fast-spreading strain in new boosters
Regulator cites teen vaping in decision against the country’s market leader
US prepares to roll out jabs to last age group without access once regulatory approval is received
Protein-based vaccine is an alternative to mRNA technology used by BioNTech/Pfizer and Moderna
Congressional probe found 22 consultants had advised both the US FDA and drug manufacturers over a decade
FDA’s green light for aducanumab may delay development of more effective treatments for dementia, critics say
Agency that controls spending by government health schemes will not fund drug for most patients
UK drugmaker’s R&D chief says abandoning market would have little impact
US drugs regulator says it needs more time to evaluate low-dose jab for children under 5
After decades of false starts, scientists are beginning to believe that modified organs from animals can help solve the global shortage
GSK product given as few as six times a year while current regimen requires daily pills
Concerns raised over Robert Califf’s previous stint at the US drugs regulator and its approach to the opioid epidemic
Food and Drug Administration had previously limited third doses to those who were vulnerable
US expected to become first country to authorise vaccine for younger children
Data from drugmaker and US regulator suggest advantages of Covid-19 jab would far outweigh risks
People at high risk of catching coronavirus can now receive any of three vaccines authorised by US health agency
Regulator signals it will allow devices to help smokers quit but not flavours popular with teens
Panel recommends third jabs for vulnerable people in step towards expanding US rollout of extra doses
Ivermectin has been touted by conservative commentators despite not being approved for use against virus
Agency decision to restrict third jabs to vulnerable Americans deals blow to Biden’s strategy
International Edition
